| SC 13G/A | 2024-02-14 | Avidity Partners Management LP | Kezar Life Sciences, Inc. | 5,025,454 | 6.9% | EDGAR |
| SC 13G/A | 2024-02-14 | ORBIMED ADVISORS LLC | Kezar Life Sciences, Inc. | 1,927,000 | 2.7% | EDGAR |
| SC 13G | 2024-02-14 | BARCLAYS PLC | Kezar Life Sciences, Inc. | 3,827,356 | 5.3% | EDGAR |
| SC 13G/A | 2024-02-13 | SUVRETTA CAPITAL MANAGEMENT, LLC | Kezar Life Sciences, Inc. | 7,167,591 | 9.9% | EDGAR |
| SC 13G/A | 2024-02-13 | Prosight Management, LP | Kezar Life Sciences, Inc. | 3,365,333 | 4.6% | EDGAR |
| SC 13G/A | 2024-01-29 | BlackRock Inc. | Kezar Life Sciences, Inc. | 4,817,266 | 6.6% | EDGAR |
| SC 13G/A | 2024-01-23 | STATE STREET CORP | Kezar Life Sciences, Inc. | - | 1.5% | EDGAR |
| SC 13G/A | 2024-01-22 | MILLENNIUM MANAGEMENT LLC | Kezar Life Sciences, Inc. | 2,927,563 | 4.0% | EDGAR |
| SC 13D/A | 2023-08-17 | Morningside Venture Investments Ltd | Kezar Life Sciences, Inc. | 1,947,993 | 2.7% | EDGAR |
| SC 13G | 2023-06-21 | MILLENNIUM MANAGEMENT LLC | Kezar Life Sciences, Inc. | 3,780,534 | 5.2% | EDGAR |
| SC 13G | 2023-04-21 | Prosight Management, LP | Kezar Life Sciences, Inc. | 4,073,229 | 5.8% | EDGAR |
| SC 13G/A | 2023-02-14 | Avidity Partners Management LP | Kezar Life Sciences, Inc. | 6,782,400 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-14 | BB BIOTECH AG | Kezar Life Sciences, Inc. | 3,000,000 | 4.4% | EDGAR |
| SC 13G | 2023-02-14 | ORBIMED ADVISORS LLC | Kezar Life Sciences, Inc. | 3,495,122 | 5.1% | EDGAR |
| SC 13G/A | 2023-02-13 | SUVRETTA CAPITAL MANAGEMENT, LLC | Kezar Life Sciences, Inc. | 3,504,264 | 5.1% | EDGAR |
| SC 13G | 2023-02-03 | STATE STREET CORP | Kezar Life Sciences, Inc. | - | 6.2% | EDGAR |
| SC 13G | 2023-02-03 | BlackRock Inc. | Kezar Life Sciences, Inc. | 4,230,913 | 6.2% | EDGAR |
| SC 13G/A | 2023-01-31 | FRANKLIN RESOURCES INC | Kezar Life Sciences, Inc. | 1,365,323 | 2.0% | EDGAR |
| SC 13G/A | 2023-01-17 | MILLENNIUM MANAGEMENT LLC | Kezar Life Sciences, Inc. | 2,896,495 | 4.2% | EDGAR |
| SC 13G | 2022-06-23 | MILLENNIUM MANAGEMENT LLC | Kezar Life Sciences, Inc. | 3,026,628 | 5.0% | EDGAR |